Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gilead Sciences on Thursday posted a higher-than-expected third-quarter profit on the back of strong demand for its HIV and cancer drugs, which helped offset lower sales of its COVID-19 antiviral drug and acquisition expenses.
Amarin Corporation plc (NASDAQ:NASDAQ:AMRN) Q3 2022 Results Earnings Conference Call October 27, 2022, 08:00 AM ET Company Participants Lisa DeFrancesco - Senior Vice President, Corporate...
By Deena Beasley (Reuters) - Gilead Sciences Inc on Thursday posted a higher-than-expected third-quarter profit on the back of strong demand for its HIV and cancer drugs, which helped offset lower sales of its COVID-19
Gilead Sciences Inc on Thursday posted a higher-than-expected third-quarter profit on the back of strong demand for its HIV and cancer drugs, which helped offset lower sales of its COVID-19 antiviral
Biogen Inc. (NASDAQ:NASDAQ:BIIB) Q3 2022 Earnings Conference Call October 25, 2022 08:00 AM ET Company Participants Mike Hencke - Head, Investor Relations Michel Vounatsos - Chief Executive...